Apr 22, 2003|
SARS: Desperate to get connected?
While the rest of the (relevant economic) world has spent all their time trying to limit the damage of SARS, the Indian government has probably been trying to find a SARS patient to prove that yes, India does matter in the greater global scheme of things!
The SARS virus proves or, rather, re-confirms, two things:
human beings are subject to a “biological attack” from sources other than the “axis of evil”, and
India is not an economically relevant country in the global scheme of things.
While exposure to biological attacks from natural disasters is unlikely to lessen the resolve of the Bush administration to go about dismantling any evil empires, the failure of SARS in the Indian context (in one sense a huge blessing) should encourage our distracted politicians to step back and examine where India stands in the global economy. Or even what the acronym SARS means. For those who believe that SARS means Sab Aye Ram Se (I have never doubted the belief in the Creator), I think that CNN and the media are talking about the virus SARS. But what, you may ask, is the connection between SARS and the global economy?
Elementary, my dear Watson.
Data gathered from www.cnn.com and the WHO websites suggests that, as of April 21, 2003 there are 4,059 reported cases of SARS worldwide and 211 deaths due to the virus. Of the 4,059 reported cases, China had a “market share” of 44.5%, HK had 34.5%, Canada had 6.7%, Singapore had 4.4%, Taiwan had 0.7%, USA had 5.4%, and Vietnam had 1.6%. Between them the 7 countries (including China and HK with 79%) had a total of 97.8% of all the reported cases. India has reported one confirmed case so far – 0.025% market share.
Well, the countries with a high market share of SARS cases all have significant trade or investments with China. China has been one of the engines of the global economy (the other being the consumer in USA) and one of the unintended consequences of this higher travel (that accompanies this higher trade with China) has been SARS. The pattern is unmistakable: If your country is a significant statistic in the global trade business, SARS is likely to be a concern for the country. If you are irrelevant in the global trade field (as our dear politicians have ensured India is), then SARS is (thankfully?) not a worry.
So, while the rest of the (relevant economic) world has spent all their time trying to limit the damage of SARS, the Indian government has probably been trying to find a SARS patient to prove that yes, India does matter in the greater global scheme of things!
On a more serious note, while SARS is indeed a terrible new disease, press reports suggest that more people die of flu in USA (30,000 a year) so SARS is not that fatal in comparison. And from an Indian perspective, the government needs to plug itself more into the global economy, beef up its infrastructure (health facilities, too), and market India as an alternative investment destination.
More Views on News
Jul 25, 2017
Equitymaster HQ has been infiltrated. Valuable stock ideas have been leaked. Who's responsible?
May 27, 2017
What happens when minority shareholders are short-changed in the normal course of business?
Feb 15, 2017
PersonalFN believes SEBI has taken a step back-apparently in the admission of it going overboard with the regulations.
Aug 24, 2016
And here's your chance to claim a free copy of this book...
Aug 12, 2016
And Why India's demographic dividend could turn out to be a doubtful debt...
More Views on News
Aug 10, 2017
Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.
Aug 10, 2017
Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.
Aug 12, 2017
The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.
Aug 10, 2017
Bitcoin hits an all-time high, is there more upside left?
Aug 16, 2017
Ensure your financial Independence, and pledge to start the journey towards financial freedom today!
Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement. LEGAL DISCLAIMER:
Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here
. The performance data quoted represents past performance and does not guarantee future results.SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: firstname.lastname@example.org. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407